Recently, it was reported that TAM may be the predominant source of LPA production in the ascites of ovarian cancer patients via a consecutive action by platelet-activating factor acetylhydrolase (PAF-AH) and ATX [12]. Here, ENPP2 is linked to ovarian carcinoma.